Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Receivables (2016 - 2025)

National Healthcare (NHC) has disclosed Receivables for 16 consecutive years, with $157.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Receivables rose 2.22% year-over-year to $157.7 million, compared with a TTM value of $157.7 million through Dec 2025, up 2.22%, and an annual FY2025 reading of $157.7 million, up 2.22% over the prior year.
  • Receivables was $157.7 million for Q4 2025 at National Healthcare, up from $132.4 million in the prior quarter.
  • Across five years, Receivables topped out at $157.7 million in Q4 2025 and bottomed at $94.3 million in Q1 2021.
  • Average Receivables over 5 years is $117.6 million, with a median of $112.2 million recorded in 2021.
  • The sharpest move saw Receivables dropped 6.09% in 2021, then increased 29.87% in 2025.
  • Year by year, Receivables stood at $115.0 million in 2021, then grew by 3.3% to $118.8 million in 2022, then rose by 7.38% to $127.6 million in 2023, then rose by 20.93% to $154.3 million in 2024, then increased by 2.22% to $157.7 million in 2025.
  • Business Quant data shows Receivables for NHC at $157.7 million in Q4 2025, $132.4 million in Q3 2025, and $142.1 million in Q2 2025.